A review of more than 100 studies suggests that balancing hormone levels may reverse factors that increase heart disease risk in some female athletes. The review is published ahead of print in the American Journal of Physiology—Heart ...
Aug 27, 2019
0
2
For women depending on steroids to treat severe asthma, their body's estrogen may not only be preventing the treatment from working effectively, but making the asthma worse, according to a recent Western study.
May 9, 2019
0
1
Metastatic breast cancers treated with hormone therapy can become treatment-resistant when they acquire mutations in the human epidermal growth factor receptor 2 (HER2) that were not present in the original tumor, reports ...
Dec 11, 2018
0
58
Exercise may reduce the risk of osteoporosis associated with the loss of ovarian function, but fitness may not protect against related metabolic changes and weight gain, a new study reports. The findings will be presented ...
Oct 1, 2018
0
0
Research published today reveals a potential mechanism for migraine causation which could explain why women get more migraines than men. The study, in Frontiers in Molecular Biosciences, suggests that sex hormones affect ...
Aug 14, 2018
0
29
Transgender individuals may be at higher risk for myocardial infarction and death due to cardiovascular disease, according to several studies. This increased risk may be due to the hormone therapy that transgender patients ...
Aug 3, 2018
0
6
A new treatment for pain caused by endometriosis was approved Tuesday by U.S. regulators.
Jul 24, 2018
0
21
Premature birth alters the balance of interneurons in the cerebral cortex that can be restored with estrogen treatment, according to a study of human brain tissue and preterm rabbits published in JNeurosci.
Jul 23, 2018
0
4
Women are more prone to the development of autoimmune diseases. The female hormone estrogen is likely to affect the immune system. A team of scientists from Turku Center for Biotechnology and University of Georgia reported ...
Jun 1, 2018
0
430
A University of Illinois at Chicago-developed breast cancer drug that has the potential to help women whose cancer has stopped responding to hormone therapy recently entered its first human clinical trial.
Mar 22, 2018
0
19
